oligonucleotide peptide conjugation oligonucleotide conjugation

Dr. James Peterson logo
Dr. James Peterson

oligonucleotide peptide conjugation conjugated - Peptide oligonucleotide conjugationchemistry and therapeutic applications Peptide–oligonucleotide conjugation chemistry and therapeutic applications Unlocking Advanced Therapeutics: The Science Behind Oligonucleotide Peptide Conjugation

Oligonucleotideconjugates for therapeutic applications The field of molecular biology and therapeutics is constantly evolving, with new strategies emerging to enhance the efficacy and delivery of therapeutic agents. Among these, oligonucleotide peptide conjugation stands out as a powerful approach, creating novel molecular constructs that merge the distinct yet complementary properties of peptides and oligonucleotides. These sophisticated peptide oligonucleotide conjugates (POCs), also referred to as oligonucleotide conjugates, are not merely simple combinations but rather covalent architectures designed to overcome inherent limitations of individual components, paving the way for more targeted and effective treatments.

The fundamental principle behind oligonucleotide peptide conjugation lies in covalently linking a peptide sequence to an oligonucleotide.Peptide–oligonucleotide conjugates as nanoscale building ... This can be achieved through various attachment points on the oligonucleotide, including the base, the sugar unit at the 3'- or 5'-positions, or even the backbone. Similarly, the peptide can be linked at different positionsDNA Peptide Conjugates. This versatility in attachment allows for fine-tuning of the resulting conjugate's properties.Stepwise synthesis of oligonucleotide–peptide conjugates ... A primary driver for this type of conjugation is the inherent instability of oligonucleotides in biological systems. The addition of a peptide component can significantly protect the oligonucleotide from degradation, a crucial factor for enhancing its therapeutic lifespan and efficacyOligonucleotide-peptide conjugates as potential antisense .... Furthermore, the peptide moiety can impart specific targeting capabilitiesPeptide–LNA oligonucleotide conjugates. For instance, certain peptides are known to bind to proteins on the surface of cells, thereby facilitating the targeted delivery of the oligonucleotide to specific tissues or cell types.作者:CJ Serpell—Peptide-oligonucleotide conjugates (POCs)have now emerged as building blocks in nanotechnology. We review recent advances in the self-assembly ... This targeted delivery is a cornerstone of modern therapeutic strategies, aiming to maximize therapeutic impact while minimizing off-target effects.

The chemistry underpinning oligonucleotide peptide conjugation is diverse and continually being refined.Peptide-Oligonucleotide Conjugation One of the most explored and historically significant strategies for conjugation of a peptide with an oligonucleotide is through an amide linkage. This involves the reaction of an amino group on one molecule with an activated carboxyl group on the other. Beyond amide bonds, other chemical strategies are widely employed for forming a covalent bond between peptide and oligonucleotide fragments.Peptide–oligonucleotide conjugates as nanoscale building ... These include the use of oxime, thiazolidine, and hydrazine groups, offering alternative pathways for creating stable linkages.Peptide-Oligonucleotide Conjugates (POCs) for ... Recent advancements have also introduced more efficient and sustainable approaches, such as catalytic methods for preparing POCs linked with an amide bond, demonstrating a move towards greener chemistry in bioconjugation2024年5月6日—Peptide−oligonucleotide conjugates(POCs) are covalent architectures composed of a DNA or RNA molecules linked to apeptide.. Native chemical ligation (NCL) has also emerged as an efficient strategy for synthesizing specific types of oligonucleotide-peptide conjugates, such as CPP-ASO conjugates, where CPP stands for cell-penetrating peptide.Targeted Delivery of Oligonucleotide–Peptide Conjugates for ...

The applications of peptide-oligonucleotide conjugates are rapidly expanding, spanning various therapeutic areas and research domains. Their ability to combine the targeting and delivery capabilities of peptides with the specific molecular recognition and therapeutic potential of oligonucleotides makes them invaluable tools. For instance, oligonucleotide-peptide conjugates are being investigated as potential antisense agents for interfering with RNA function, offering a more precise way to modulate gene expression. The conjugation of peptides to oligonucleotides is widely used to improve their delivery and therapeutic potential. Studies have shown that oligonucleotide conjugation can lead to significant increases in delivery efficiency; for example, peptides have led to a 14-fold increase in delivery in some cases.

Beyond therapeutic applications, peptide-oligonucleotide conjugates are also proving to be powerful building blocks in nanotechnologyPeptide–LNA oligonucleotide conjugates. Their ability to undergo self-assembly allows for the creation of higher-ordered, protein-like structures, opening new avenues for biomaterials and molecular engineering. The precise control over the assembly process, driven by the specific interactions between the peptide and oligonucleotide components, enables the design of complex nanostructures with tailored functions.

The enhanced uptake observed in certain tissues, such as the outer layer of the kidney (cortex), for oligonucleotide-peptide conjugates highlights their potential for targeted drug delivery. This specific localization suggests a promising avenue for treating kidney-related diseases.作者:T MacCulloch·2019·被引用次数:77—Peptide–oligonucleotide conjugates (POCs) are covalent constructs that link a molecule like DNA to a syntheticpeptidesequences. Furthermore, oligonucleotide conjugates create opportunities to deliver the oligonucleotide to a specific cell or tissue and to fine-tune 'drug-like' properties, thereby improving their pharmacokinetic profiles and reducing systemic toxicity.

In summary, oligonucleotide peptide conjugation represents a sophisticated strategy for developing next-generation therapeutics and advanced materials.2024年9月24日—Chemical conjugation of oligonucleotidesis widely used to improve their delivery and therapeutic potential. A variety of strategies are ... By leveraging the synergistic properties of peptides and oligonucleotides, these conjugates offer enhanced stability, improved cellular uptake, targeted delivery, and novel functionalities, positioning them at the forefront of scientific innovation. The ongoing research into novel conjugation chemistries and the exploration of their diverse applications underscore the immense potential of peptide-oligonucleotide conjugates in addressing complex biological challenges and advancing human health.

Log In

Sign Up
Reset Password
Subscribe to Newsletter

Join the newsletter to receive news, updates, new products and freebies in your inbox.